Genotype/phenotype correlations in Wilms' tumor

Medical and Pediatric Oncology

Volumn 27, Issue 5, 1996, Pages 408-414

  Huff, Vicki ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

genetic variants; WAGR syndrome; Wilms' tumor

Indexed keywords

ARTICLE; CHILD; CHROMOSOME 11P; CHROMOSOME DELETION; DRASH SYNDROME; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NEPHROBLASTOMA; PHENOTYPE; PRIORITY JOURNAL; UROGENITAL TRACT MALFORMATION;

ALLELES; AMINO ACID SEQUENCE; ANTISENSE ELEMENTS (GENETICS); CHILD; CONSENSUS SEQUENCE; DNA TRANSPOSABLE ELEMENTS; DNA-BINDING PROTEINS; EXONS; FEMALE; GENE DELETION; GENES, WILMS TUMOR; GENOTYPE; HAPLOIDY; HUMANS; IRIS; KIDNEY NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; SYNDROME; TRANSCRIPTION FACTORS; UROGENITAL ABNORMALITIES; WILMS TUMOR; WT1 PROTEINS; ZINC FINGERS;

EID: 0029797218     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199611)27:5<408::AID-MPO4>3.0.CO;2-Q     Document Type: Article

References (55)

1. Riccardi VM, Sujansky E, Smith AC, Francke U: Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 61:604-610, 1978.
2. Davis LM, Stallard R, Thomas GH, Couillin P, Junien C, Nowak NJ, Shows TB: Two anonymous DNA segments distinguish the Wilms' tumor and aniridia loci. Science 241:840-842, 1988.
3. Porteous DJ, Bickmore W, Christie S, Boyd PA, Cranston G, Fletcher JM, Gosden JR, Rout D, Seawright A, Simola KOJ, van Heyningen V, Hastie ND: HRAS1-selected chromosome transfer generates markers that colocalize aniridia- and genitourinary dysplasia-associated translocation breakpoints and the Wilms tumor gene within band 11p13. Proc Natl Acad Sci USA 84:5355-5359, 1987.
4. Breslow NE, Beckwith JB: Epidemiological features of Wilms' tumor: Results of the National Wilms' Tumor Study. J Natl Cancer Inst 68:429-436, 1982.
5. Geiser CF, Schindler AM: Long survival in a male with 18-trisomy syndrome and Wilms' tumor. Pediatrics 44:111-116, 1969.
6. Karayalcin G, Shanske A, Honigman R: Wilms' tumor in a 13-year-old girl with trisomy 18. Am J Dis Child 135:665-666, 1981.
7. Olson JM, Hamilton A, Breslow NE: Non-11p constitutional chromosome abnormalities in Wilms' tumor patients. Med Pediatr Oncol 24:305-309, 1995.
8. Hartley AL, Birch JM, Tricker K, Wallace SA, Kelsey AM, Harris M, Morris Jones PH: Wilms' tumour in the Li-Fraumeni cancer family syndrome. Cancer Genet Cytogenet 67:133-135, 1993.
9. Schimmenti LA, Cich JA, Gorlin RJ, Berry S: Autosomal dominant inheritance of Wilms' tumor and branchial cleft anomalies. Am J Hum Genet Suppl 53:502, 1993.
10. Kakinuma A, Morimoto I, Nakano Y, Fujimoto R, Ishida O, Okada Y, Inokuchi N, Fujihira T, Eto S: Familial primary hyperparathyroidism complicated with Wilms' tumor. Intern Med 33:123-126, 1994.
11. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, Thakker RV, Huff V, Leppert MF, Heath H: Hereditary hyperparathyroidism-Jaw tumor syndrome: The endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56:944-950, 1995.
12. Kondo K, Chilcote RR, Maurer HS, Rowley JD: Chromosome abnormalities in tumor cells from patients with sporadic Wilms' tumor. Cancer Res 44:5376-5381, 1984.
13. Slater RM: The cytogenetics of Wilms' tumor. Cancer Genet Cytogenet 19:37-41, 1986.
14. Douglass EC, Wilimas JA, Green AA, Look AT: Abnormalities of chromosomes 1 and 11 in Wilms' tumor. Cancer Genet Cytogenet 14:331-338, 1985.
15. Solis V, Pritchard J, Cowell JK: Cytogenetic changes in Wilms' tumors. Cancer Genet Cytogenet 34:223-234, 1988.
16. Kaneko Y, Homma C, Maseki N, Sakurai M, Hata J: Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res 51:5937-5942, 1991.
17. Wang-Wuu S, Soukup S, Bove K, Gotwals B, Lampkin B: Chromosome analysis of 31 Wilms' tumors. Cancer Res 50:2786-2793, 1990.
18. Maw M, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, Callen DF, Thompson AD, Richards RI, Reeve AE: A third Wilms' tumor locus on chromosome 16q. Cancer Res 52:3094-3098, 1992.
19. Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC: Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 54:2331-2333, 1994.
20. Malkin D, Sexsmith E, Yeger H, Williams BRG, Coppes MJ: Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor. Cancer Res 54:2077-2079, 1994.
21. Waber PG, Chen J, Nisen PD: Infrequency of ras, p53, WT1, or RB gene alterations in Wilms' tumors. Cancer 72:3732-3738, 1993.
22. Bardeesy N, Falkoff D, Petruzzi M-J, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J: Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genet 7:91-97, 1994.
23. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520, 1990.
24. Gessler M, Proustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP: Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778, 1990.
25. Rauscher FJ III, Morris JF, Tournay OE, Cook DM, Curran T: Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259-1262, 1990.
26. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJ III: Transcriptional repression mediated by the WT1 Wilms' tumor gene product. Science 253:1550-1553, 1991.
27. Wang Z-Y, Qui Q-Q, Deuel TF: The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains J Biol Chem 268:9172-9175, 1993.
28. Steinmetz M, Uematsu Y, Lindahl KF: Hotspots of homologous recombination in mammalian genomes. Trends Genet 3:7-10, 1987.
29. Krawczak M, Cooper DN: Gene deletions causing human genetic disease: Mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet 86:425-441, 1991.
30. Gessler M, Konig A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F, Cavenee W, Bruns G: Infrequent mutation of the WT1 gene in 77 Wilms' tumors. Hum Mutat 3:212-222, 1994.
31. Huff V, Jaffe N, Saunders GF, Strong LC, Villalba F, Ruteshouser EC: WT1 exon 1 deletion/insertion mutations in Wilms' tumor patients associated with di- and trinucleotide repeats and deletion hotspot consensus sequences. Am J Hum Genet 56:84-90, 1995.
32. Knudson AG, Strong LC: Mutation and cancer: A model for Wilms' tumor of the kidney. J Natl Cancer Inst 48:313-324, 1972.
33. Huff V, Miwa H, Haber DA, Call KM, Housman D, Strong LC, Saunders GF: Evidence for WT1 as a Wilms tumor (WT) gene: Intragenic germinal deletion in bilateral WT. Am J Hum Genet 48:997-1003, 1991.
34. Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, Coad N, de Pagter-Holthuizen P, Pearson PL: Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet 81:41-48, 1988.
35. Reeve AE, Sih SA, Raizis AM, Feinberg AP: Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol 9:1799-1803, 1989.
36. Wadey RB, Pal N, Buckle B, Yeomans E, Pritchard J, Cowell JK: Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. Oncogene 5:901-907, 1990.
37. Moulton T, Crenshaw T, Hao Y, Moosikasawan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, Kraus W, Gerald W, Tycko B: Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet 7:440-447, 1994.
38. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP: Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet 7:433-439, 1994.
39. Gessler M, Konig A, Bruns GAP: The genomic organization and expression of the WT1 gene. Genomics 12:807-813, 1992.
40. Park S, Bernard A, Bove KE, Sens DA, Hazen-Martin DJ, Garvin AJ, Haber DA: Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nature Genet 5:363-367, 1993.
41. Brown KW, Wilmore HP, Watson JE, Mott MG, Berry PJ, Maitland NJ: Low frequency of mutations in the WT1 coding region in Wilms' tumor. Genes Chromosome Cancer 8:74-79, 1993.
42. Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE: WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 353:431-434, 1991.
43. Schneider S, Wildhardt G, Ludwig R, Royer-Pokora B: Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations. Hum Genet 91:599-604, 1993.
44. Santos A, Osorio-Almeida L, Baird PN, Silva JM, Boavida MG, Cowell J: Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome. Hum Genet 92:83-86, 1993.
45. Veranasi R, Bardeesy N, Ghahremani M, Petruzzi M-J, Nowak N, Adam MA, Grundy P, Shows TB, Pelletier J: Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci USA 91:3554-3558, 1994.
46. Little MH, Presser J, Condie A, Smith PJ, Van Heyningen V, Hastie ND: Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci USA 89:4791-4795, 1992.
47. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE: An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61:1257-1269, 1990.
48. Akasaka Y, Kikuchi H, Nagai T, Hiraoka N, Kato S, Hata J: A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. FEBS Lett 317:39-43, 1993.
49. Coppes MJ, Huff V, Pelletier J: Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr 123:673-678, 1993.
50. Nordenskjold A, Friedman E, Anvret M: WT1 mutations in patients with Denys-Drash syndrome: A novel mutation in exon 8 and paternal allele origin. Hum Genet 93:115-120, 1994.
51. Little MH, Williamson KA, Mannens M, Kelsey A, Gosden C, Hastie ND, van Heyningen V: Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet 2:259-264, 1993.
52. Sakai A, Tadokoro K, Yanagisawa H, Nagafuchi S, Hoshikawa N, Suzuki T, Kohsaka T, Hasegawa T, Nakahori Y, Yamada M: A novel mutation of the WT1 gene (a tumor supressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome. Hum Mol Genet 2:1969-1970, 1993.
53. Konig A, Jakubiczka S, Wieacker P, Schlosser HW, Gessler M: Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome. Hum Mol Genet 2:1967-1968, 1993.
54. Ogawa O, Eccles MR, Yun K, Mueller RF, Holdaway MDD, Reeve AE: A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. Hum Mol Genet 2:203-204, 1993.
55. Bardeesy N, Zabel B, Schmitt K, Pelletier J: WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 21:663-665, 1994.